Jordi Salas-Salvadó is currently Professor of Human Nutrition and Bromatology of the Faculty of Medicine and Health Sciences at the Rovira i Virgili University in Spain and Head of Nutrition of the Internal Medicine Service, at Sant Joan University Hospital of Reus. He is also Vice-Dean / Head of Studies of the Degree in Human Nutrition and Dietetics of the Rovira i Virgili University.
In last years, expertise and research lines of Dr Salas are focused in human clinical trials evaluating the effect of diets and dietary compounds on obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. Since 2005, he is one of the leaders of PREDIMED STUDY, considerate the best clinical trial evaluating the effect of the Mediterranean Diet on cardiovascular diseases. He is the coordinator and member of the Steering Committee of the PREDIMED-PLUS STUDY, a multi-centre, randomised, primary prevention trial on 6000 overweight or obese participants (55-75 years) with metabolic syndrome. The project is aimed to determine the effect on adiposity, cardiovascular disease and mortality and quality of life, of an intensive weight loss intervention based on a traditional hypocaloric Mediterranean Diet, physical activity promotion and behavioural therapy compared to a less intensive program using Mediterranean diet (without energy restriction or physical activity). The recruitment started in September 2013 and will finish in June 2016. Final results will be available in 2020.
Since 1983 Dr. Salas has directed 18 research projects financed by public bodies and 23 projects in conjunction with the pharmaceutical or food industries. He has published more than 290 original articles in national and international journals, as well as numerous reviews and editorials. Editor of 6 books, he has also co-authored more than 50 books.
Read here more about his research.
